AltMountain

Medtech Convergence Fund, L.P.

Boston, MA · CIK 1770396
Status: no Form D since Mar 2019. Funds file a Form D when they begin selling and amend it each year while the offering continues, so this fund has most likely stopped raising money. It may still be investing, or it may have closed or been dissolved. The details below are from its latest filing, kept here as a record.

Medtech Convergence Fund, L.P. is a venture capital fund based in Boston, Massachusetts. Its most recent Form D, filed Mar 12, 2019, reports no sales yet. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Aaron Sandoski; Paul LaViolette; Medtech Convergence GP LLC.

Total raised
$0Cumulative sales reported on Form D
Investors
0
First sale
—
Minimum investment
None set
Who can invest
Qualified purchasersSection 3(c)(7): generally $5M+ in investments
Offering exemption
Rule 506(b)No general advertising
Key people and entities
Aaron Sandoski; Paul LaViolette; Medtech Convergence GP LLC
Latest Form D
Mar 12, 2019

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction

Questions about Medtech Convergence Fund, L.P.

What is the minimum investment for Medtech Convergence Fund, L.P.?

Medtech Convergence Fund, L.P.'s latest Form D, filed Mar 12, 2019, does not set a minimum investment. Managers can still require one in the offering documents.

Who can invest in Medtech Convergence Fund, L.P.?

Medtech Convergence Fund, L.P. is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.

How much has Medtech Convergence Fund, L.P. raised?

Medtech Convergence Fund, L.P.'s latest Form D, filed Mar 12, 2019, reports no sales yet.

Where is Medtech Convergence Fund, L.P. based?

Medtech Convergence Fund, L.P. is based in Boston, Massachusetts.

Size compared with every venture capital fund

This fund hasn't reported any sales yet.

More venture capital funds in Boston

Recently filed venture capital funds in Massachusetts

All venture capital funds in Massachusetts